Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 121 to 135 of 1191 results for pain

  1. What is the most clinically and cost-effective timing and dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be moderate to severe?

    dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be...

    Research recommendation
    Published
    26 October 2020

  2. Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    Question Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness...

    Research recommendation
    Published
    9 June 2015

  3. Psychological therapy – mindfulness for chronic primary pain: What is the clinical and cost effectiveness of mindfulness therapy for managing chronic primary pain in people aged 16 years and over?

    mindfulness for chronic primary pain: What is the clinical and cost effectiveness of mindfulness therapy for managing chronic primary...

    Research recommendation
    Published
    6 August 2021

  4. Peripheral nerve-field stimulation for chronic low back pain (IPG451)

    Evidence-based recommendations on peripheral nerve-field stimulation for chronic low back pain. This involves implanting electrodes in the back, connected to a neurostimulator under the skin to mask the back pain by modulating the transmission of pain signals to the brain.

    Interventional procedures guidance
    Published
    27 March 2013
    View recommendations

    Sections for IPG451

  5. Stapled haemorrhoidopexy for the treatment of haemorrhoids (TA128)

    Evidence-based recommendations on stapled haemorrhoidopexy for treating haemorrhoids in adults.

    Technology appraisal guidance
    Published
    26 September 2007
    View recommendations

    Sections for TA128

  6. Transcranial magnetic stimulation for chronic primary pain: What is the clinical and cost effectiveness of transcranial magnetic stimulation for managing chronic primary pain in people aged 16 years and over?

    chronic primary pain: What is the clinical and cost effectiveness of transcranial magnetic stimulation for managing chronic primary...

    Research recommendation
    Published
    6 August 2021

  7. Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    neuropathic pain? Any explanatory notes(if applicable) There has been some suggestion that some pharmacological agents for neuropathic...

    Research recommendation
    Published
    26 October 2020

  8. Oral health for adults in care homes (NG48)

    This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.

    NICE guideline
    Published
    5 July 2016
    View recommendations

    Sections for NG48

  9. Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)

    Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.

    Highly specialised technologies guidance
    Last updated
    8 April 2025
    View recommendations

    Sections for HST8

  10. Constipation in children and young people: diagnosis and management (CG99)

    This guideline covers diagnosing and managing constipation in children and young people up to 18. It provides strategies to support the early identification and timely, effective treatment of constipation which will help improve outcomes for patients. It does not cover constipation caused by a specific condition.

    Clinical guideline
    Last updated
    13 July 2017
    View recommendations

    Sections for CG99

  11. Acute coronary syndromes in adults (QS68)

    This quality standard covers diagnosing and managing acute coronary syndromes in adults (aged 18 and over). Acute coronary syndromes are medical emergencies that include myocardial infarction (heart attack) and unstable angina (unexpected, severe chest pain). It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    18 November 2020
    View quality statements

    Sections for QS68

  12. Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)

    Evidence-based recommendations on relugolix–estradiol–norethisterone (Ryeqo) for treating symptoms of endometriosis in adults of reproductive age.

    Technology appraisal guidance
    Published
    16 April 2025

    Sections for TA1057

  13. What is the effectiveness of pain management for women who present with chronic pain 3 months after mesh surgery for stress urinary incontinence or pelvic organ prolapse?

    Question What is the effectiveness of pain management for women who present with chronic pain 3 months after mesh surgery...

    Research recommendation
    Published
    21 June 2019

  14. Atogepant for treating migraine [ID6615]

    In development Reference number: GID-TA11817 Expected publication date:  09 July 2026

    Technology appraisal guidance
    In development

  15. Pancreatic cancer (QS177)

    This quality standard covers diagnosis of pancreatic cancer and management of pancreatic ductal adenocarcinoma in adults aged over 18. This quality standard describes high-quality care in priority areas for improvement. It does not cover national initiatives, such as cancer screening or audit.

    Quality standard
    Published
    20 December 2018
    View quality statements

    Sections for QS177